Newsfile Corp
03 May 2026, 16:00 UTC · 28w ago
Bronstein, Gewirtz & Grossman LLC Urges Soleno Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Impact · against what's priced in
The filing of a class action lawsuit against Soleno Therapeutics alleging concealed safety concerns regarding fluid retention in DCCR trials creates significant regulatory and commercial risk. While lawsuits are common, the specific allegation of misrepresented Phase 3 data directly threatens the drug's approval prospects and peak sales potential.
- SES−0.30
No priced-in read yet





